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Abstract
Multi-modality imaging is rapidly becoming an essential tool in oncology. Clinically, the best example of multimod-
ality imaging is seen in the rapid evolution of hybrid positron emission tomography (PET)/computed tomography
(CT) and single positron emission computed tomography (SPECT)/CT scanners. However, use of multi-modality
imaging is prone to artefacts and pitfalls. Important artefacts that may lead to clinical misinterpretation result from the
use of CT data to correct for attenuation and the existence of mismatches between the fused images, for example due
to respiratory movement. Furthermore, for institutions who proceed from a standalone PET to a hybrid PET-CT, there
is an issue of interchangeability between these systems, especially for quantitative studies. Another issue is visualisa-
tion: hospital PACS is not sufficiently capable of adequately viewing integrated images. This article reviews and
illustrates the most common artefacts and pitfalls that can be encountered in multi-modality nuclear medicine
imaging. For correct management of oncological patients it is essential to be able to detect and correctly interpret
these artefacts and pitfalls. Therefore, solutions and recommendations to these problems are provided.
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Introduction
Integrating anatomic and functional information poten-
tially allows improved lesion localisation and character-
isation. Better diagnostic accuracy and staging are
fundamental in the management of oncological patients
and can directly influence therapeutic decisions. Hence,
multimodality imaging is an important achievement in
the fields of oncology, nuclear medicine, radiology and
radiation oncology.
In the past few years there has been a strong migration
from dedicated positron emission tomography (PET)
scanners to hybrid positron emission tomography/com-
puted tomography (PET/CT) scanners in hospitals
worldwide. These integrated systems have led to more
accurate information in investigations using
[18F]fluorodeoxyglucose (FDG), in particular with
regard to lesion localisation[13] and in radiotherapy
treatment planning[4,5]. Also single positron emission
computed tomography (SPECT) systems combined
with CT have gained in popularity within the nuclear
medicine community.
CT-based attenuation correction is usually performed
with combined PET/CT or SPECT/CT systems. As CT
scans are more rapid than conventional transmission
scans using electronically windowed rotating rod sources
such as germanium-68/gallium-68 (Ge-68/Ga-68), this
reduces the time needed for overall whole-body PET
scanning by up to 50%[6].
However, especially due to the use of CT for attenua-
tion correction and movement of (organs of) patients, the
use of multi-modality systems in clinical practice is not
free from pitfalls and imaging artefacts. Moreover, when
patients get follow-up PET scans on both a standalone
PET and PET-CT, this may lead to misinterpretation in
semi-quantitative studies due to a difference in attenua-
tion correction. Since an increasing number of institu-
tions will proceed from a standalone PET to a hybrid
PET-CT scanner, this issue becomes increasingly rele-
vant. Furthermore, current standard picture archiving
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and communication systems (PACS) do not provide ade-
quate and reliable tools for visualisation of multi-modality
image sets, which prevents hospital-wide reviewing and
demonstration of image fusion. Finally, multi-modality
imaging implies an increase in imaging data. Optimised
protocols have to prevent an overwhelming volume of
data being presented to referring specialists.
In this article, we review the imaging artefacts and pit-
falls that can be encountered when using combined PET/
CT or SPECT/CT systems. Furthermore, we quote solu-
tions and recommendations on how to deal with these
issues and how to apply multi-modality systems into the
multi-disciplinary environment of a hospital.
Imaging artefacts and pitfalls
Inevitably, the technology of hybrid PET/CT suffers from
artefacts of its own[7,8]. Artefacts may occur on CT
images due to metallic implants, contrast agents and trun-
cation. When CT data are used for scatter and attenua-
tion corrections of the PET images, these artefacts can
have subsequent effects in PET/CT images. Furthermore,
due to patient movement or respiratory movement, addi-
tional imaging problems such as misregistration or erro-
neous attenuation correction, may occur.
CT-induced artefacts
Due to high photon absorption, metallic implants such as
dental fillings or hip prosthetics, generate streaking arte-
facts on CT images[9,10]. As attenuation for electron
dense areas at CT energies (up to 140 keV) is typically
an order of magnitude higher than attenuation at the PET
photon energy (511 keV), an overestimation of PET
activity can be expected in those areas after CT-based
attenuation correction. Hence, this may lead to a false--
positive PET finding. An illustration of this phenomenon
is given in Fig. 1. The same type of artefacts and PET
misinterpretation may result from the use of CT contrast
agents such as iodine and barium sulphate, which are
used to delineate vessels and soft tissue on CT[1113].
The magnitude of the error induced by CT contrast
agents in the corrected PET images is not significant in
many cases in clinical practice[1416]. Because of the
more similar photon energies of CT and SPECT radio-
pharmaceuticals, the issues of these CT-induced artefacts
are much less of a problem than they are for PET/CT.
Awareness of these possible artefacts is the first step in
dealing with them. It is recommended to always use PET
images that are not corrected for attenuation (uncor-
rected PET), as they never manifest these types of arte-
facts. They should be interpreted in conjunction with the
corrected images. Furthermore, algorithms are proposed
to properly transform CT attenuation coefficients in the
electron dense regions from CT energies to 511 keV. In
general, segmenting the region of a CT dense area and
replacing it by lower CT numbers, forms the basis of
these algorithms[13,17].
Truncation artefacts may also occur[18,19] when the
field of view (FOV) of the PET is larger than the FOV
of the CT[20]. These artefacts arise when positioning
patients away from the in-plane centre of the PET/CT
gantry or when imaging large patients. As a patient
extends beyond the CT FOV, no attenuation values
exist for the PET data in the corresponding region.
This results in an underestimation of activity concentra-
tion on the attenuation-corrected PET images, potentially
resulting in misinterpretation of the PET scan.
An algorithm to compensate for truncation artefacts
on corrected PET images is suggested by Beyer et
al.[18]. By artificially creating an extended FOV of the
CT, which matches the PET FOV, the truncated regions
can be recovered to a high degree.
Motion-induced artefacts
Patient motion leads to artefacts in the reconstructed
PET images as there is a difference in acquisition time
Figure 1 Hybrid PET/CT (Siemens LSO Biograph 2, Siemens Medical Solutions, USA) of the hip area. Shown are
transverse slices of CT (a), uncorrected PET (b) and attenuation-corrected PET (c). The hip prosthetic results in severe
artefacts on CT, which subsequently results in a seemingly high uptake on the corrected PET (white arrows), not present
on the uncorrected PET. The PET hot-spot at the far right side of the patient (blue arrow) is a true-positive (bursitis).
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of the PET and CT. Although use of fixation masks, belts
or cushions and good instructions by technologists may
help in minimising the overall patient movement, one
cannot prevent artefacts due to respiratory movement,
as demonstrated by several investigators[2023]. Mainly
in the upper abdomen and thorax one has to be aware
of severe problems as a discrepancy exists in the position
of organs (and thus of lesions) in those regions between
the CT and the uncorrected PET image. PET images are
acquired during free breathing, as the acquisition time is
relatively long (several minutes per bed position). CT is
usually acquired during a specific stage of the breathing
cycle. Especially in the region around the diaphragm,
where a sharp transition exists on CT between liver
and lung tissue, severe misinterpretations may occur[21].
For example, an apparent contour change of the liver on
CT-based attenuation-corrected PET images may be
observed. In addition, there can be a reduced sensitivity
for lesions in the affected area and the PET signal will no
longer be quantitative in the regions of attenuation cor-
rection artefacts, which may compromise follow-up mea-
surements. An example of such an induced artefact is
demonstrated in Fig. 2.
Without a comprehensive breathing protocol, motion
artefacts occur frequently[22]. A recommendation that
can easily be implemented in clinical practice is that
patients hold their breath at mid-expiration or mid-inspi-
ration[20,24]. However, maintaining an unforced expira-
tion breathhold is easily underestimated. Especially
elderly or diseased patients will fail to sustain breathhold
during actual scanning, causing artefacts on CT such as
deformities throughout the liver. In the lungs, this causes
small lung nodules to be missed in up to 34% of cases[25].
This problem is obviously related to the acquisition time
for CT during whole-body scanning. The faster the CT
scanner, or the more CT detector rows, the better
breathhold compliance will be. For patients who are
unable to comply with any breathhold instructions, res-
piration induced artefacts are reduced when using PET/
CT systems employing CT components with an increas-
ing amount of detector rows[26].
Even in an ideal situation, with a fast, multi-slice
CT scanner, accurate breathhold instructions and an
exemplary patient, the exact position of the diaphragm
during instructed breathhold cannot be predicted.
Furthermore, the shape of the diaphragm may differ
from free breathing, because breathhold generates differ-
ent muscle tension. This implies that differences in posi-
tion and shape of the liver between PET and breathhold
CT may be unavoidable and severe. This is illustrated by
Goerres et al.[27] where an optimised breathing protocol
results in differences in diaphragm position on expiration
breathhold CT and free breathing PET between 25 and
þ19mm. A solution to this unpredictable problem is
respiratory gating. Several investigators[2830] propose a
phased attenuation correction in respiration correlated
CT/PET which can lead to a more precise lesion localisa-
tion and quantification of the activity.
Another way to address motion-induced artefacts on
PET is to perform attenuation correction on the basis
of transmission scans using, e.g. rotating Ge-68/Ga-
68 rod sources, although most current hybrid PET/CT
scanners lack this option. Respiratory motion during
such transmission scans is similar to that during the emis-
sion acquisition. Consequently, a better correlation of the
diaphragm position is expected and hence a better atten-
uation correction in regions with sharp tissue/air transi-
tion[21,31]. Disadvantages of using traditional rod sources
are the longer scanning time with respect to CT and the
higher statistical noise than CT data in the final attenu-
ation-corrected PET image.
Figure 2 Hybrid PET/CT (Siemens LSO Biograph 2, Siemens Medical Solutions, USA) of a liver metastasis (blue and
red arrows), with CT acquired during inspiration breathhold. Coronal slices of uncorrected PET/CT (a), attenuation
corrected PET/CT (b) and a transverse CT slice (c) are shown. A difference in diaphragm position between CT and
uncorrected PET (white arrows) is visible (a). (b) demonstrates a change in shape of the liver on PET after attenuation
correction, to falsely match CT. The liver metastasis appears in the lung on the corrected PET image (blue arrow), and
suffers from severe loss of signal intensity. (c) shows the lesion is within the liver (red arrow).
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Finally, there could be a role for software fusion. When
image registration is performed with uncorrected PET and
CT images, followed by the attenuation correction proce-
dure, artefacts to respiratory motion can be reduced.
Unfortunately, current hybrid PET/CT scanners do not
provide this option. However, software fusion is foreseen
to become an important tool, not only for the correction of
residual motion-induced misregistration within combined
PET/CT data sets, but also for follow-up studies involving,
for example, dedicated CT, dedicated PET, PET/CT, and
magnetic resonance imaging (MRI)[32,33].
Additional pitfalls of hybrid PET/CT and
SPECT/CT
Although integrated PET/CT and SPECT/CT systems
are advertised extensively as state-of-the-art and as the
latest achievement in modern medicine technology, some
obvious pitfalls should not be forgotten. These hybrid
scanners result in unnecessary duplication of CT scans,
since in most cases, a patient will already have had a
diagnostic CT exam before the PET study. To avoid
poor radiation safety practice, one can implement an
adapted diagnostic strategy by considering that in certain
clinical conditions, obtaining a diagnostic CT before
PET/CT may not be necessary. Furthermore, for many
patients integrated PET/CT (or SPECT/CT) provides the
same information that could be obtained from side-by-
side imaging of a standalone CT and PET (or SPECT).
Finally, a pitfall of multi-modality systems is that lesions
can be overlooked when merely focusing on fused (over-
laid) image results. The information that is depicted in
the separate images is not fully present in an overlaid
representation. For optimal reviewing of integrated
image sets, visualisation of adjacent separate image sets
as well as an overlaid image set is needed. The overlaid
image set should be used for localisation purposes only.
Ge-68/Ga-68-based versus CT-based
attenuation correction
Traditionally, for standalone PET imaging, attenuation
correction is performed using transmission scans with
electronically windowed rotating rod sources such as
Ge-68/Ga-68, or rotating point sources such as cae-
sium-137 (Cs-137). Therefore, if the activity concentra-
tion in a certain region within the patient is sufficiently
high, e.g. in a tumour, the photons emitted by the radio-
pharmaceutical that was injected into the patient, dis-
turbs the rod- or point-source-based attenuation
correction for that region. For multi-modality PET-CT
scanners, emission photons will not be measured
during the CT acquisition as it normally operates at an
energy below 140 keV. Hence, misinterpretation might
occur when patients get follow-up PET scans on both a
standalone PET and PET-CT. As institutions proceed
from a single-modality PET to a multi-modality PET-CT
scanner, this issue will become increasingly relevant,
especially when quantitative values are compared across
imaging systems.
Emission contamination is easily demonstrated. Fig. 3
shows a Ge/Ga-based attenuation map and an attenua-
tion-corrected PET image of a sphere with a diameter of
60mm, using a full-ring dedicated PET scanner (Siemens
ECAT Exact 47, Siemens/CTI, USA). The activity con-
centration in the sphere was 100 kBq/ml FDG. Instead of
a close to uniform attenuation map, we observe a deple-
tion in the attenuation coefficient in the sphere, due to
the emission contamination. Consequently, the activity
concentration derived from the corrected PET image is
underestimated by tens of percent. Moreover, the activity
Figure 3 A Ge/Ga-based attenuation map (a) and a attenuation-corrected FDG-PET image of a sphere with a diameter
of 60mm in a water environment (b,c) (Siemens ECAT Exact 47, Siemens/CTI, USA). The scale is such that zero
corresponds to no recovery and 100 to full recovery. The activity concentration in the sphere was 100 kBq/ml. Instead
of a close to uniform attenuation map, we observe a depletion in the attenuation coefficient in the sphere (a), due to the
emission contamination. Consequently, the activity concentration derived from the corrected PET image is underesti-
mated by tens of percent (b,c).
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concentration in the centre of the sphere is approxi-
mately 30% lower with respect to the concentration at
the border of the sphere. This could erroneously be inter-
preted as central necrosis. Using CT for attenuation cor-
rection, we would not observe these biases.
The literature confirms these phenomena. Nakamoto
et al.[34] showed that CT-based attenuation correction pro-
duced activity concentration values significantly higher
than the Ge/Ga-based corrected values: mean and maxi-
mum radioactivity concentrations were 4.315.2% higher
for CT-corrected images than for Ge/Ga-corrected images.
By performing a Ge/Ga-based transmission scan before
injection of the radiopharmaceutical, which is obviously
the ideal situation, but not always practical, one can pre-
vent emission contamination to occur. With this gold stan-
dard, Van der Weerdt et al.[35] showed that post
transmission scans for attenuation correction in cardiac
FDG-PET scans resulted in substantial underestimation of
FDG activity up to 15%.
One method is suggested to perform a correction for
the emission contamination, using a dwell profile[3537].
Although the correction method is not extremely compli-
cated, it is generally not, or insufficiently, implemented in
clinical PET. Therefore, another possibility to partially
compensate for the emission contamination would be
to perform a cross calibration: using a phantom close
to the patients geometry, translations can be derived
from a measured standardized uptake value (SUV) on
a standalone PET to a measured SUV on a PET/CT.
Obviously, for follow-up studies, it is best that scans are
acquired on the same system for each patient.
What about hybrid PET/MRI?
MRI is superior to CT in visualisation and delineation of
soft tissue anatomy. The combination of PET with MRI
may therefore be preferable over PET/CT, also in terms
of radiation protection. However, breathing issues remain
an issue. Current MRI techniques do not allow whole-
body imaging during breathhold, and free breathing
during MRI can severely distort the images. At this
moment, the best approach to hybrid PET/MRI is
unclear. Still, due to the potential advantages of a com-
bination of PET and MRI over combined PET/CT sys-
tems, clinical PET/MRI systems are eagerly awaited.
Initial measurements with one PET detector module in
a 7 T field during application of MRI sequences by
Pichler et al.[38] were encouraging. Recently, the design
of a micro-PET/MRI system has been completed, and
assembly and testing is underway[39].
Multi-modality imaging and PACS
Visualisation of fused multi-modality
imaging
For optimal interpretation and discussion of multi-
modality imaging, visualisation of both the separate
images and the fused images is necessary. Dedicated
image fusion software, that runs on a single or limited
number of dedicated computer stations in the depart-
ments where the actual scanning is done, e.g. the radiol-
ogy and nuclear medicine departments, provides this
functionality. Although availability of fused multi-modal-
ity images through a picture archiving and communica-
tion system (PACS) benefits the entire hospital[40,41],
exporting of the integrated image sets to a PACS is usu-
ally not provided, or in a very limited way only. This
omission in functionality can first be explained by the
lack of a Digital Imaging and Communications in
Medicine (DICOM) standard for integrated image sets,
and second by the lack of visualisation and linking tools
for integrated image sets in current PACS systems.
Therefore, there is no generally accepted method to trans-
fer these image sets to a PACS, or for subsequent visua-
lisation of the images. This blocks access to the
integrated image sets from computer systems other
than the fusion workstation itself, and prevents presenta-
tion of the fused images to physicians in other depart-
ments. Also, this seriously limits interdisciplinary
discussions in, for example, surgical or oncological work-
groups. In the current era of growing connectivity and
accessibility, this is not acceptable.
Until PACS vendors provide easy and adequate image
fusion software in their systems, a useful alternative would
be to produce an alternating DICOM series file that con-
tains alternating separate and fused representations of
anatomically corresponding slices from different
scans[42]. Subsequently, such a file can then be displayed
in standard PACS either serialized or side-by-side. In the
serial configuration, stepping through the images in one
viewing frame will reveal different representations of a
single slice, before moving on to the next slice. Stepping
backwards and forwards through the images will suggest a
useful toggle mechanism. Alternatively, the alternating
images can be displayed adjacently by showing multiple
slices on a single screen. An example, based on software
fusion of MRI and SPECT, is given in Fig. 4.
Increased imaging data
The amount of acquired imaging data per patient is grow-
ing each year. Better resolution and new imaging techni-
ques result in an enormous amount of data, which is
difficult for referring physicians to handle. Moreover,
potentially every image can be fused with all other
images, by which the amount of data would even grow
more. Hence, a strategy is necessary to limit the amount
of available images for physicians, such that all pertinent
information is still present.
First, it should be realised that image fusion impacts
on the management of patients in only a limited amount
of cases. Based on clinical experience with PET and
CT, Jager et al.[43] showed that there is no need to
look at CT images in about 80% of cases. They also
showed that in the majority of the remaining 20% of
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cases, side-by-side imaging of the two modalities provides
sufficient information. Hence, only in a small part of the
patient population and only in a small number of lesions
does image fusion have additional value. Therefore,
image fusion should not be performed in all situations.
The following protocol is suggested. After acquiring
the images, both the uncorrected and corrected PET
images, and the CT image, should be used to generate
the clinical report. At the end, one or more summary
screenshots are created, indicating the location of a
lesion on PET, the corresponding CT and the fused
result. These summaries are the only fused images that
should be sent to PACS and thus can be used during
multi-disciplinary discussions hospital-wide.
Conclusion
Better diagnostic accuracy and staging are of pivotal
importance for the adequate management of oncological
patients. Multi-modality imaging, for example using
hybrid PET/CT, contributes to this goal. However, the
use of integrated imaging modalities in clinical practice is
prone to imaging artefacts and pitfalls. Patient and respi-
ratory movement, resulting in misalignment of the images
and biases in CT-based attenuation correction, are impor-
tant issues in combined PET/CT systems. Lack of ade-
quate and reliable tools for visualisation of multi-modality
image sets in hospital PACS, which prevents hospital-
wide reviewing and demonstration of image fusion, is
another important issue. Awareness of possible artefacts
and pitfalls and being able to detect, correctly interpret
and possibly solve them, is necessary for a maximum
diagnostic yield.
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